BRK-B vs MLCI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
MLCI exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating a near-total failure of fundamental health metrics. While the company trades at a significant discount to book value (P/B 0.57), this is offset by catastrophic profitability margins (-137.62% profit margin) and a negative ROE of -62.40%. Despite a high current ratio suggesting short-term liquidity, the technical trend is completely bearish (0/100) and quarterly revenue has plummeted by 44.54%. The dividend appears unsustainable given the lack of earnings.
Compare Another Pair
Related Comparisons
BRK-B vs MLCI: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Mount Logan Capital Inc. (MLCI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.